IDEXX Laboratories, Inc. (IDXX)

CIK 0000874716 · Healthcare · Diagnostics and Research

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-04) · 99.1
Q1-2026 8-K (2026-05-05) · 99.1
Latest FY-2025 8-K (2026-02-02) · 99.1
Q3-2025 8-K (2025-11-03) · 99.1
Q2-2025 8-K (2025-08-04) · 99.1
Q1-2025 8-K (2025-05-01) · 99.1
FY-2024 8-K (2025-02-03) · 99.1
Q3-2024 8-K (2024-10-31) · 99.1
Q2-2024 8-K (2024-08-06) · 99.1
Q1-2024 8-K (2024-05-01) · 99.1
FY-2023 8-K (2024-02-05) · 99.1
Q3-2023 8-K (2023-11-01) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Income
Consolidated Statements of Comprehensive Income
Consolidated Statements of Comprehensive Income (P)
Consolidated Statements of Stockholders Equity
Consolidated Statements of Stockholders Equity (P)
Consolidated Statements of Cash Flows
Notes
Accounting Policies
—
Accounts Payable, Accrued Liabilities and Other Long-term Liabilities
Accrued Liabilities
—
Accumulated Other Comprehensive Income
Acquisitions, Asset Purchases and Investments
Basis of Presentation and Principles of Consolidation
—
Commitments, Contingencies and Guarantees
Credit Losses
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Earnings Per Share
Fair Value Measurements
Goodwill and Intangible Assets, Net
—
Hedging Instruments
Idexx Retirement and Incentive Savings Plan
—
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Inventories
Lease Commitments
Leases
Nature of Business, Basis of Presentation and Principles of Consolidation
—
Other Current and Long-term Assets
Pay Vs Performance Disclosure
Preferred Stock
—
Property and Equipment, Net
—
Repurchases of Common Stock
Revenue
Revenue Recognition
—
Segment Reporting
Share-based Compensation
Summary of Significant Accounting Policies
—